C. R. Bard
 |
|
| Public | |
| Traded as | : BCR S&P 500 Component |
| Founded | 1907 |
| Founder | Charles Russell Bard |
| Headquarters | New Providence, New Jersey, U.S. |
|
Area served
|
Worldwide |
|
Key people
|
Timothy M. Ring (Chairman) & (CEO) |
| Products | Vascular, Urology, Oncology, and Surgical Specialties |
| Revenue |
 US$2.72B (FY 2010)
|
|
US$730M (FY 2010)
|
|
|
US$509M (FY 2010)
|
|
| Total assets |
US$3.17B (FY 2010)
|
| Total equity |
 US$1.63B (FY 2010)
|
|
Number of employees
|
14,000 (2015) |
| Website | www |
C. R. Bard, Inc., now branded simply as Bard, headquartered in Murray Hill, New Jersey, USA, is a leading multinational developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. An S&P 500 company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the Foley catheter in 1934. In 2013, Bard began negotiations to settle nearly 30,000 legal claims related to implantable vaginal meshes made by the company.
C. R. Bard, Inc. was founded in New York City by Charles R. Bard in 1907. Bard's first business involved importing Gomenol, which was used to treat urinary discomfort. The company formally incorporated in 1923, and three years later, in 1926, Charles R. Bard sold the company to John F. Willits and Edson L. Outwin for $18,000. Under Willits and Outwins, the company expanded into the catheter business, introducing the Foley catheter in 1934 and the America Woven Catheter in 1940.
In 1948, Bard's annual sales topped $1 million for the first time, and the company moved its headquarters from New York City to Summit, New Jersey. In 1954, a Bard scientist, Dr. DeBakey, developed the first arterial prosthesis. Three years later the company began selling Foley catheters that came in sterile packaging for the first time ever. Bard continued to innovate in the world of catheters, rolling out the Bipolar Temporary Pacing catheter in 1958 and the first latex balloon catheter in 1960. In 1961, Bard expanded beyond catheters, and began manufacturing products related to cardiology, radiology, and anesthesiology.
...
Wikipedia